Arthritis is an inflammatory condition that affects people worldwide leading to disabilities and decreasing the quality of life. Rheumatoid Arthritis (RA) is the most prevalent inflammatory arthritis that has triggered a revolution of treatment options over the last few decades. Though there is currently no cure for the condition, treatment regimens focus on alleviating symptoms, [&hellip;]

Adalimumab as a treatment choice for Rheumatoid Arthritis- a pharmacoeconomic perspective - DDReg pharma

Adalimumab as a treatment choice for Rheumatoid Arthritis- a pharmacoeconomic perspective

Comment

Home

DDReg pharma

https://resource.ddregpharma.com/wp-content/uploads/2022/12/logo-ddreg.png

https://secure.gravatar.com/avatar/b4c9a289323b21a01c3e940f150eb9b8c542587f1abfd8f0e1cc1ffc5e475514?s=96&d=mm&r=g